UBS Initiates Coverage On Tyra Biosciences with Buy Rating, Announces Price Target of $28

Benzinga · 01/07 12:44
UBS analyst Eliana Merle initiates coverage on Tyra Biosciences (NASDAQ:TYRA) with a Buy rating and announces Price Target of $28.